<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS AND BACKGROUND: Myeloid differentiation primary response gene 88 (MYD88) is a protein involved in hematopoietic differentiation and innate immunity </plain></SENT>
<SENT sid="1" pm="."><plain>Recent studies revealed MYD88 mutation in <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematological malignancies</z:e> and MYD88 overexpression in some solid <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this study was to see whether alterations of MYD88 protein expression and <z:hpo ids='HP_0001428'>somatic mutation</z:hpo> of MYD88 gene are features of common solid <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We analyzed MYD88 mutation in 45 gastric, 45 colorectal, 45 breast, 45 hepatocellular, 45 prostate and 45 <z:mp ids='MP_0008714'>lung carcinomas</z:mp> by single-strand conformation polymorphism (SSCP) </plain></SENT>
<SENT sid="4" pm="."><plain>We also analyzed MYD88 protein expression in 60 gastric, 60 coloretal and 107 prostate <z:mp ids='MP_0002038'>carcinomas</z:mp> by immunohistochemistry </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: In the immunohistochemistry results, MYD88 protein was highly expressed in gastric (75%), colorectal (80%) and prostate (83%) <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>However, MYD88 expression was significantly different among <z:mpath ids='MPATH_458'>normal</z:mpath> tissues (gastric: 58%, colon: 100%, prostate: 86%) </plain></SENT>
<SENT sid="7" pm="."><plain>MYD88 expression was significantly increased in <z:hpo ids='HP_0012126'>gastric cancer</z:hpo> cells compared with <z:mpath ids='MPATH_458'>normal</z:mpath> cells, whereas it was decreased in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells compared with <z:mpath ids='MPATH_458'>normal</z:mpath> cells </plain></SENT>
<SENT sid="8" pm="."><plain>There were no <z:hpo ids='HP_0001428'>somatic mutations</z:hpo> of the MYD88 gene in gastric, colorectal, breast, hepatocellular, prostate and <z:mp ids='MP_0008714'>lung carcinomas</z:mp> </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Our data indicate that MYD88 overexpression might be a feature of many solid <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, but MYD88 expression in <z:mpath ids='MPATH_458'>normal</z:mpath> cells differs depending on the organs </plain></SENT>
<SENT sid="10" pm="."><plain>The data suggest that a gain of MYD88 expression in <z:hpo ids='HP_0012126'>gastric cancers</z:hpo> might play a role in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> pathogenesis by activating oncogenic functions of MYD88 </plain></SENT>
</text></document>